Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
【発明の名称】組合せ医薬および胃腸疾患の処置へのそれらの使用
Document Type and Number:
Japanese Patent JP2003523324
Kind Code:
A
Abstract:
The present invention relates to a combination of a first agent inducing either a 5-HT 4 receptor agonist or antagonist or a 5-HT 3 receptor antagonist and a co-agent and pharmaceutical compositions and formulations containing the combination. The pharmaceutical combination may be employed for the treatment of altered gastrointestinal motility, sensitivity, secretion or abdominal disorders. The dosage is preferably oral. The preferred first agent is tegaserod.

Inventors:
Stephan Anthony Bilstein
Peter Dumovic
Nicola Franco
Mark Thomas Iwicki
Hans-Jürgen Pfunkukche
Edward Joseph Wills Jr.
Application Number:
JP2001543093A
Publication Date:
August 05, 2003
Filing Date:
December 08, 2000
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
Novartis Actien Gezel Shaft
International Classes:
A61K31/135; A61K31/138; A61K31/195; A61K31/197; A61K31/341; A61K31/404; A61K31/4045; A61K31/4439; A61K31/451; A61K31/485; A61K45/06; A61P1/00; A61P1/04; A61P1/08; A61P1/10; A61P1/12; A61P1/14; (IPC1-7): A61K45/06; A61K31/404; A61P1/00; A61P1/04; A61P1/08; A61P1/10; A61P1/12; A61P1/14
Domestic Patent References:
JPH0586026A1993-04-06
Foreign References:
WO1999017755A21999-04-15
WO1999011277A11999-03-11
Attorney, Agent or Firm:
Kaoru Aoyama (3 people outside)